Filing Details
- Accession Number:
- 0001431373-11-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-14 12:00:00
- Reporting Period:
- 2011-02-14
- Filing Date:
- 2011-02-14
- Accepted Time:
- 2011-02-14 16:04:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1003124 | Pharmaceutical Product Development Inc | PPDI | Services-Commercial Physical & Biological Research (8731) | 561640186 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1431373 | O. Michael Wilkinson | 929 N. Front Street Wilmington NC 28401 | Chief Information Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-02-14 | 12,421 | $19.94 | 14,125 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2011-02-14 | 12,075 | $25.74 | 26,200 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-02-14 | 24,496 | $28.84 | 1,704 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (to buy) | Disposition | 2011-02-14 | 12,421 | $0.00 | 12,421 | $19.94 |
| Common Stock | Stock Options (to buy) | Disposition | 2011-02-14 | 12,075 | $0.00 | 12,075 | $25.74 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 6,211 | 2009-11-20 | 2018-11-20 | No | 4 | M | Direct |
| 24,152 | 2010-02-18 | 2019-02-18 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (to buy) | $26.64 | 2011-06-17 | 2020-06-17 | 15,000 | 15,000 | Direct |
| Common Stock | Stock Options (to buy) | $20.45 | 2011-02-25 | 2020-02-25 | 31,052 | 31,052 | Direct |
| Common Stock | Stock Options (to buy) | $37.69 | 2009-10-03 | 2018-10-03 | 18,632 | 18,632 | Direct |
| Common Stock | Stock Options (to buy) | $33.80 | 2008-09-27 | 2017-09-27 | 62,104 | 62,104 | Direct |
| Common Stock | Stock Options (to buy) | $43.26 | 2009-02-20 | 2018-02-20 | 7,763 | 7,763 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2020-06-17 | 15,000 | 15,000 | Direct |
| 2020-02-25 | 31,052 | 31,052 | Direct |
| 2018-10-03 | 18,632 | 18,632 | Direct |
| 2017-09-27 | 62,104 | 62,104 | Direct |
| 2018-02-20 | 7,763 | 7,763 | Direct |
Footnotes
- Includes shares acquired under the automatic dividend reinvestment provision of the Company's Employee Stock Purchase Plan.
- The price shown is a weighted average; the shares were sold at prices ranging from $28.75 to $28.92. Upon request by the Commission staff, the issuer or a security holder of the issuer, full informaiton regarding the number of shares at each separate price is available.
- The options vest in 1/3 increments on 6/17/11, 6/17/12 and 6/17/13.
- The options vest in 1/3 increments on 2/25/11, 2/25/12 and 2/25/13.
- The options vest in 1/3 increments on 11/20/09, 11/20/10 and 11/20/11.
- The options will vest in 1/3 increments on 10/8/09, 10/8/10 and 10/8/11.
- The options vest in 1/3 increments on 9/27/08, 9/27/09 and 9/27/10.
- The options vest in 1/3 increments on 2/20/09, 2/20/10 and 2/20/11.
- The options vest in 1/3 increments on 2/18/10, 2/18/12 and 2/18/12.
Billionaire Hedge Funds
